Mammary branch initiation and extension are inhibited by separate pathways downstream of TGFβ in culture

Experimental Cell Research

Volumn 317, Issue 13, 2011, Pages 1872-1884

  Pavlovich, Amira L ^a   Boghaert, Eline ^a   Nelson, Celeste M ^a,b  

^a Princeton University   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

3D; MAPK; Microfabrication; Morphogen gradient

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHOGEN; TRANSFORMING GROWTH FACTOR BETA; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; BRANCHING MORPHOGENESIS; BREAST EPITHELIUM; CONTROLLED STUDY; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 79958228344     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.03.017     Document Type: Article

References (80)

1. Xie W., Paterson A.J., Chin E., Nabell L.M., Kudlow J.E. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol. 1997, 11:1766-1781.
2. Fowler K.J., Walker F., Alexander W., Hibbs M.L., Nice E.C., Bohmer R.M., Mann G.B., Thumwood C., Maglitto R., Danks J.A., Chetty R., Burgess A.W., Dunn A.R. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 1995, 92:1465-1469.
3. Sebastian J., Richards R.G., Walker M.P., Wiesen J.F., Werb Z., Derynck R., Hom Y.K., Cunha G.R., DiAugustine R.P. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ. 1998, 9:777-785.
4. Veltmaat J.M., Mailleux A.A., Thiery J.P., Bellusci S. Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation 2003, 71:1-17.
5. Lu P., Ewald A.J., Martin G.R., Werb Z. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev. Biol. 2008, 321:77-87.
6. Parsa S., Ramasamy S.K., De Langhe S., Gupte V.V., Haigh J.J., Medina D., Bellusci S. Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev. Biol. 2008, 317:121-131.
7. Ewan K.B., Shyamala G., Ravani S.A., Tang Y., Akhurst R., Wakefield L., Barcellos-Hoff M.H. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am. J. Pathol. 2002, 160:2081-2093.
8. Silberstein G.B., Flanders K.C., Roberts A.B., Daniel C.W. Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1. Dev. Biol. 1992, 152:354-362.
9. Silberstein G.B., Strickland P., Coleman S., Daniel C.W. Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland. J. Cell Biol. 1990, 110:2209-2219.
10. Daniel C.W., Robinson S.D. Regulation of mammary growth and function by TGF-beta. Mol. Reprod. Dev. 1992, 32:145-151.
11. Daniel C.W., Silberstein G.B., Van Horn K., Strickland P., Robinson S. TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. Dev. Biol. 1989, 135:20-30.
12. Robinson S.D., Silberstein G.B., Roberts A.B., Flanders K.C., Daniel C.W. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development 1991, 113:867-878.
13. Silberstein G.B., Daniel C.W. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 1987, 237:291-293.
14. Pierce D.F., Johnson M.D., Matsui Y., Robinson S.D., Gold L.I., Purchio A.F., Daniel C.W., Hogan B.L., Moses H.L. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev. 1993, 7:2308-2317.
15. Crowley M.R., Bowtell D., Serra R. TGF-beta, c-Cbl, and PDGFR-alpha the in mammary stroma. Dev. Biol. 2005, 279:58-72.
16. Joseph H., Gorska A.E., Sohn P., Moses H.L., Serra R. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol. Biol. Cell 1999, 10:1221-1234.
17. Cheng N., Bhowmick N.A., Chytil A., Gorksa A.E., Brown K.A., Muraoka R., Arteaga C.L., Neilson E.G., Hayward S.W., Moses H.L. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-MSP- and HGF-mediated signaling networks. Oncogene 2005, 24:5053-5068.
18. Ingman W.V., Robertson S.A. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects. Biol. Reprod. 2008.
19. Affolter M., Zeller R., Caussinus E. Tissue remodelling through branching morphogenesis. Nat. Rev. Mol. Cell Biol. 2009, 10:831-842.
20. Brinkmann V., Foroutan H., Sachs M., Weidner K.M., Birchmeier W. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J. Cell Biol. 1995, 131:1573-1586.
21. Hirai Y., Lochter A., Galosy S., Koshida S., Niwa S., Bissell M.J. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J. Cell Biol. 1998, 140:159-169.
22. Niemann C., Brinkmann V., Spitzer E., Hartmann G., Sachs M., Naundorf H., Birchmeier W. Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J. Cell Biol. 1998, 143:533-545.
23. Simian M., Hirai Y., Navre M., Werb Z., Lochter A., Bissell M.J. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001, 128:3117-3131.
24. Soriano J.V., Pepper M.S., Nakamura T., Orci L., Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 1995, 108(Pt 2):413-430.
25. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., Weidner K.M., Birchmeier C., Birchmeier W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 1995, 131:215-226.
26. Bergstraesser L., Sherer S., Panos R., Weitzman S. Stimulation and inhibition of human mammary epithelial cell duct morphogenesis in vitro. Proc. Assoc. Am. Physicians 1996, 108:140-154.
27. Reichmann E., Ball R., Groner B., Friis R.R. New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J. Cell Biol. 1989, 108:1127-1138.
28. Young P.R., McLaughlin M.M., Kumar S., Kassis S., Doyle M.L., McNulty D., Gallagher T.F., Fisher S., McDonnell P.C., Carr S.A., Huddleston M.J., Seibel G., Porter T.G., Livi G.P., Adams J.L., Lee J.C. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 1997, 272:12116-12121.
29. Tong L., Pav S., White D.M., Rogers S., Crane K.M., Cywin C.L., Brown M.L., Pargellis C.A. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 1997, 4:311-316.
30. Nelson C.M., Vanduijn M.M., Inman J.L., Fletcher D.A., Bissell M.J. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 2006, 314:298-300.
31. Hirai Y., Radisky D., Boudreau R., Simian M., Stevens M.E., Oka Y., Takebe K., Niwa S., Bissell M.J. Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta. J. Cell Biol. 2001, 153:785-794.
32. Nelson C.M., Inman J.L., Bissell M.J. Three-dimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression. Nat. Protoc. 2008, 3:674-678.
33. Snedeker S.M., Brown C.F., DiAugustine R.P. Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc. Natl. Acad. Sci. USA 1991, 88:276-280.
34. Schroeder J.A., Lee D.C. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 1998, 9:451-464.
35. Coleman-Krnacik S., Rosen J.M. Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol. Endocrinol. 1994, 8:218-229.
36. Pedchenko V.K., Imagawa W. Pattern of expression of the KGF receptor and its ligands KGF and FGF-10 during postnatal mouse mammary gland development. Mol. Reprod. Dev. 2000, 56:441-447.
37. Vonderhaar B.K. Local effects of EGF, alpha-TGF, and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo. J. Cell. Physiol. 1987, 132:581-584.
38. Ruan W., Newman C.B., Kleinberg D.L. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc. Natl. Acad. Sci. USA 1992, 89:10872-10876.
39. Coleman S., Silberstein G.B., Daniel C.W. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev. Biol. 1988, 127:304-315.
40. Sternlicht M.D., Sunnarborg S.W., Kouros-Mehr H., Yu Y., Lee D.C., Werb Z. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 2005, 132:3923-3933.
41. Fata J.E., Mori H., Ewald A.J., Zhang H., Yao E., Werb Z., Bissell M.J. The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium. Dev. Biol. 2007, 306:193-207.
42. Niranjan B., Buluwela L., Yant J., Perusinghe N., Atherton A., Phippard D., Dale T., Gusterson B., Kamalati T. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 1995, 121:2897-2908.
43. Yant J., Buluwela L., Niranjan B., Gusterson B., Kamalati T. In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp. Cell Res. 1998, 241:476-481.
44. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991, 67:901-908.
45. Daniel C.W., Silberstein G.B. Postnatal development of the rodent mammary gland. The Mammary Gland: Development, Regulation, and Function 1987, Plenum Press, New York. M.C. Neville, C.W. Daniel (Eds.).
46. Shi W., Sun C., He B., Xiong W., Shi X., Yao D., Cao X. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J. Cell Biol. 2004, 164:291-300.
47. Kavsak P., Rasmussen R.K., Causing C.G., Bonni S., Zhu H., Thomsen G.H., Wrana J.L. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 2000, 6:1365-1375.
48. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
49. Katoh M., Katoh M. Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. Int. J. Mol. Med. 2009, 23:763-769.
50. Li C., Hu L., Xiao J., Chen H., Li J.T., Bellusci S., Delanghe S., Minoo P. Wnt5a regulates Shh and Fgf10 signaling during lung development. Dev. Biol. 2005, 287:86-97.
51. Loscertales M., Mikels A.J., Hu J.K., Donahoe P.K., Roberts D.J. Chick pulmonary Wnt5a directs airway and vascular tubulogenesis. Development 2008, 135:1365-1376.
52. Li C., Xiao J., Hormi K., Borok Z., Minoo P. Wnt5a participates in distal lung morphogenesis. Dev. Biol. 2002, 248:68-81.
53. Huang L., Pu Y., Hu W.Y., Birch L., Luccio-Camelo D., Yamaguchi T., Prins G.S. The role of Wnt5a in prostate gland development. Dev. Biol. 2009, 328:188-199.
54. Huguet E.L., Smith K., Bicknell R., Harris A.L. Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor. J. Biol. Chem. 1995, 270:12851-12856.
55. Jonsson M., Andersson T. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J. Cell Sci. 2001, 114:2043-2053.
56. K. Roarty, R. Serra, Wnt5a is required for proper mammary gland development and TGF-{beta}-mediated inhibition of ductal growth, Development (2007).
57. Jones F.E., Jerry D.J., Guarino B.C., Andrews G.C., Stern D.F. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ. 1996, 7:1031-1038.
58. Weaver M., Dunn N.R., Hogan B.L. Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. Development 2000, 127:2695-2704.
59. Sutherland D., Samakovlis C., Krasnow M.A. branchless Encodes a Drosophila FGF homolog that controls tracheal cell migration and the pattern of branching. Cell 1996, 87:1091-1101.
60. Costantini F., Shakya R. GDNF/Ret signaling and the development of the kidney. Bioessays 2006, 28:117-127.
61. Davies J.A. Do different branching epithelia use a conserved developmental mechanism?. Bioessays 2002, 24:937-948.
62. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351:95-105.
63. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
64. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., Valladares A., Perez L., Klein R., Nebreda A.R. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 2000, 6:109-116.
65. Allen M., Svensson L., Roach M., Hambor J., McNeish J., Gabel C.A. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 2000, 191:859-870.
66. Mudgett J.S., Ding J., Guh-Siesel L., Chartrain N.A., Yang L., Gopal S., Shen M.M. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. USA 2000, 97:10454-10459.
67. Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., Karin M. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000, 102:221-231.
68. Beardmore V.A., Hinton H.J., Eftychi C., Apostolaki M., Armaka M., Darragh J., McIlrath J., Carr J.M., Armit L.J., Clacher C., Malone L., Kollias G., Arthur J.S. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol. Cell. Biol. 2005, 25:10454-10464.
69. Liu Y., Martinez L., Ebine K., Abe M.K. Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. Dev. Biol. 2008, 314:224-235.
70. Hida M., Omori S., Awazu M. ERK and p38 MAP kinase are required for rat renal development. Kidney Int. 2002, 61:1252-1262.
71. Leung-Hagesteijn C., Hu M.C., Mahendra A.S., Hartwig S., Klamut H.J., Rosenblum N.D., Hannigan G.E. Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis. Mol. Cell. Biol. 2005, 25:3648-3657.
72. Hu M.C., Wasserman D., Hartwig S., Rosenblum N.D. p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J. Biol. Chem. 2004, 279:12051-12059.
73. Montesano R., Carrozzino F., Soulie P. Low concentrations of transforming growth factor-beta-1 induce tubulogenesis in cultured mammary epithelial cells. BMC Dev. Biol. 2007, 7:7.
74. Yang Y.A., Tang B., Robinson G., Hennighausen L., Brodie S.G., Deng C.X., Wakefield L.M. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Cell Growth Differ. 2002, 13:123-130.
75. Nomura M., Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 1998, 393:786-790.
76. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 1998, 92:797-808.
77. Weinstein M., Yang X., Li C., Xu X., Gotay J., Deng C.X. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc. Natl. Acad. Sci. USA 1998, 95:9378-9383.
78. Heyer J., Escalante-Alcalde D., Lia M., Boettinger E., Edelmann W., Stewart C.L., Kucherlapati R. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc. Natl. Acad. Sci. USA 1999, 96:12595-12600.
79. Wang C.Z., Hsu Y.M., Tang M.J. Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel. J. Cell. Physiol. 2005, 203:295-304.
80. Vogel W.F., Aszodi A., Alves F., Pawson T. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol. Cell. Biol. 2001, 21:2906-2917.